[关键词]
[摘要]
通过人工晶状体本身释放药物在药物抑制后发性白内障方面具有一定优势,局部可以达到较高药物浓度,且毒副作用小,靶向性较强。其利于原位抑制具有潜在增殖能力的细胞,在一定程度上避免直接用药而引起的副作用及损伤。能否制备一种能降低后发性白内障发生率的人工晶状体己成为眼科界众多学者的研究焦点,我们就国内外对此项研究的现状进行综述。
[Key word]
[Abstract]
Intraocular lens as a drug delivery system has certain advantages in prevention of posterior capsular opacification, which include locally high drug concentrations, slight side effects and strong targeting. It can suppress the cells which have potential proliferation ability in situ, and avoid side effects and damages caused by direct medication to certain extent. The preparation of drugs modified intraocular lens which can reduce the incidence of posterior capsular opacification has become the study focus of many scholars. The article reviews the advances of this study at present.
[中图分类号]
[基金项目]